This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr. Lu Zawistowich Rejoins Patton Boggs LLP

WASHINGTON, Feb. 12, 2013 /PRNewswire/ --  Patton Boggs LLP is pleased to announce that Lu Zawistowich, Sc.D., a nationally-recognized expert on Medicaid and Medicare, has rejoined the firm as a senior public policy advisor in the firm's Health Care, FDA and Life Sciences practice group.

(Logo: )

During the course of her distinguished career in the public and private sectors, Dr. Zawistowich has held senior leadership positions at the Medicaid and CHIP Payment and Access Commission (MACPAC), the Medicare Payment Advisory Commission (MedPAC), and the Centers for Medicare and Medicaid Services (CMS).

Dr. Zawistowich served as the founding executive director of MACPAC, which was launched under her leadership to be a trusted and credible resource for the Congress, states, and key stakeholders on Medicaid and CHIP policy.  During her tenure at MACPAC, she established the Commission's policy analysis framework, its data development strategies, and its research agenda.  Dr. Zawistowich previously served as the acting deputy director of the Center for Consumer Information and Insurance Oversight (CCIIO) at the U.S. Department of Health and Human Services (HHS) and was instrumental in standing up this organization to implement the provisions of the Affordable Care Act (ACA).

Dr. Zawistowich, who was a senior policy advisor with the firm from 2004 to 2010, returns to one of the leading health care policy and advocacy practice groups in the United States.  Her return to Patton Boggs is the latest in a series of initiatives designed to expand the firm's strategic strength in Medicaid, Medicare, and health care reform.

"We are extremely pleased to welcome Lu back to Patton Boggs," said Senator John B. Breaux, Patton Boggs senior counsel and a leader on health care issues. "She is highly regarded throughout federal agencies, Congress and health care policy circles for her knowledge of Medicaid and Medicare and her innovative, creative solutions to public policy challenges. She is a true asset to our firm."

As a principal in the firm's health care practice, Dr. Zawistowich works with clients to develop legislative, regulatory and administrative solutions to issues involving Medicaid and Medicare. She has particular experience developing innovative strategic solutions for issues involving managed care, programs for dual eligibles, drug benefits and pricing, provider payments, coverage, and coding.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs